Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-028647

EVP R&D, Chief Medical Officer sold 14,349 shares at $30.77 ($441,550)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-12-04 Sale 10b5-1 −14,349 $30.77 $441,550 68,951 D
Open-market sales · 14,349 sh · avg $30.77 · $441,550
Loading xslF345X05/form4.xml…